In vivo and in vitro methods have been used to compare the effects of opioid receptor blockade on the functional activity of the hypothalamo-pituitary-gonadal axis in adult (200 g) and sexually immature (50 g) male rats. In the adult, a single injection of the µ-receptor antagonist, naloxone (500 µg/100 g body weight, s.c), produced hypersecretions of luteinizing hormone (LH) and testosterone. Maximal serum concentrations of the two hormones were attained within 20 and 60 min respectively. In contrast, neither ICI 174864 (100 µg/100 g body weight, s.c.) nor MR2266 (150 µg/100 g body weight, s.c), which block δ- and ĸ-receptors respectively, stimulated pituitary-gonadal activity; indeed, like the saline vehicle, both tended to depress the serum LH concentration. The injection procedure was sufficient to activate the hypothalamo-pituitary-adrenal axis and, thus, the vehicle-treated controls exhibited significant increases in the plasma adrenocorticotrophin and serum corticosterone concentrations. These effects were enhanced by naloxone (500 µg/100 g body weight, s.c.) and by the ĸ-opioid receptor (MR2266, 150 µg/100 g body weight, s.c.) but not by the δ-opioid receptor antagonist (ICI 174864, 30–100 µg/100 g body weight, s.c). The increases in serum corticosterone and LH concentration induced by naloxone in adult rats were not apparent in the sexually immature (50 g) animals. To the contrary, in the young rats naloxone (250 and 500 µg/100 µg body weight, s.c.) attenuated, in a dose-dependent manner, the pronounced hypersecretion of corticosterone induced by the vehicle injection. The higher dose of the antagonist (500 µg/100 g body weight, s.c.) also overcame the significant reductions in serum LH evident 20 (p < 0.05) and 40 (p < 0.01) min after the saline injection but the lower dose (250 µg/100 g body weight, s.c.) was ineffective in this respect. In vitro, hypothalami from both adult and sexually immature rats responded to the addition of naloxone (10–8–10–6M) to the incubation medium with significant (p < 0.01) concentration-dependent increases in the release of gonadotrophin-releasing hormone (GnRH). In contrast, ICI 174864 (10"7–10–6M) and MR2266 (10-7–10-6M) had little effect on the secretion of the releasing hormone by hypothalami from rats of either group although, at the highest concentration tested, MR2266 (10–6M) precipitated a small increase in GnRH release from hypothalami from adult rats. The secretory responses of hypothalami from adult and prepubertal rats to naloxone were inhibited by the inclusion in the medium of the αi-adrenoceptor antagonist alfuzosin (10-6M) which, in the absence of naloxone, had no discernible effects on GnRH release. Receptor binding studies indicated that both the density and affinity of naloxone-sensitive opioid binding sites within the hypothalamus were similar in adult and sexually immature rats. The results demonstrate marked differences between the neuroendocrine responses of adul...